top of page

MADOPAR 250 TABLET 250 mg

Product details

Registration number: SIN06119P

Classification: Prescription Only

Active ingredients:

  • Benserazide HCl 57mg equivalent to benserazide
  • LEVODOPA

Strength:

  • 50 mg
  • 200 mg

Dosage form: TABLET

Route: ORAL

Registrant: ROCHE SINGAPORE PTE. LTD.

ATC code: N04BA02

HSA approval date: 17 May 1991

Manufacturer(s): Delpharm Milano S.r.l

Manufacturing country/countries: ITALY

What are the HSA registration number and classification for MADOPAR 250 TABLET 250 mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN06119P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for MADOPAR 250 TABLET 250 mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Benserazide HCl 57mg equivalent to benserazide
  • LEVODOPA

Strength:

  • 50 mg
  • 200 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for MADOPAR 250 TABLET 250 mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET

Route: ORAL

Source for this answer

Who is the recorded registrant for MADOPAR 250 TABLET 250 mg?

According to the HSA dataset updated 7 August 2026:

Registrant: ROCHE SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for MADOPAR 250 TABLET 250 mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Delpharm Milano S.r.l

Manufacturing country/countries: ITALY

Source for this answer

Where can I look up MADOPAR 250 TABLET 250 mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN06119P or the exact product name MADOPAR 250 TABLET 250 mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this MADOPAR 250 TABLET 250 mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this MADOPAR 250 TABLET 250 mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN06119P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page